Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
EuroPCR 25: The OCCUPI Trial
Author(s): Byeong-Keuk Kim Added: 9 months ago
EuroPCR 25 - Subgroup analysis outcomes from OCCUPI show optical coherence tomography-guided percutaneous coronary intervention (PCI) is an effective intravascular imaging technique for complex lesions, having successfully met its composite primary outcome measure.We are joined by Dr Byeong-Keuk Kim (Yonsei University College of Medicine, Seoul, KR) to discuss subgroup analysis findings from the… View more

Intervention

MI/ACS
EuroPCR 25: An ILUMIEN-IV Substudy
Author(s): Thomas Johnson Added: 9 months ago
EuroPCR 25 - Substudy findings from ILUMIEN-IV show that virtual flow reserve was slightly higher after angiography guidance rather than an optical coherence tomography (OCT)-based physiology assessment after percutaneous coronary intervention (PCI) in high-risk angiographic lesions.We are joined by Dr Thomas Johnson (Bristol Heart Institute, Bristol, UK) to discuss findings from a retrospective… View more

Imaging & Diagnostics

Intervention
Job title: Martin Bucksbaum Distinguished University Chair, Professor and Director
Research Area(s) / Expertise: Job title: Professor and Chairman of the Department of Radiology and Head of the Division of Nuclear Medicine
Lp(a) and Atherosclerosis
Author(s): Annalisa Filtz , Leandro Slipczuk , Martha Gulati Added: 1 week ago

Prevention & Chronic Conditions
The Coronary Microcirculation Re-explored
Author(s): Ahmed Elamin , Mustafa Abdimalik , Mohanad Abdelrahim , et al Added: 4 months ago

Prevention & Chronic Conditions
View from the Thoraxcenter: ESC Congress 24 Hot Line Preview
Author(s): Nicolas M Van Mieghem , Joost Daemen Added: 1 year ago
Which interventional cardiology studies will have the greatest impact at ESC 2024?Leading experts Prof Nicolas Van Mieghem and Dr Joost Daemen (Thoraxcenter, Erasmus MC, Rotterdam, NL) offer an exclusive preview of the most anticipated hot line studies set to be unveiled at ESC Congress 2024. Get their in-depth analysis of the studies and gain invaluable insights ahead of the curve.ESC Congress… View more

Intervention

MI/ACS
TCT 25: The PREVUE-VALVE Study
Author(s): David J Cohen Added: 4 months ago
TCT 2025 - The PREVUE-VALVE study finds an 8.2% prevalence of moderate or greater valvular heart disease amongst Americans age 65-85, increasing to 18.4% when participants with mild to moderate VHD were included.Dr David J. Cohen (Cardiovascular Research Foundation & St Francis Hospital, US) joins us to discuss findings from the PREVUE-VALVE study, examining age and sex-specific prevalence of… View more

Imaging & Diagnostics

Intervention
Empagliflozin and Finerenone: Hyperkalemia Risk in CKD
Added: 3 days ago Source:  Radcliffe CVRM
The CONFIDENCE trial investigated the efficacy of dual Empagliflozin & Finerenone therapy in compound CKD-T2D patients compared to Finerenone monotherapy in hyperkalemia prevention. The results suggested that dual therapy did not significantly mitigate hyperkalemia risk compared to solitary Finerenone administration.¹MethodologyThe CONFIDENCE trial was a double-blind, randomised, controlled study… View more

Cardiovascular Renal Metabolic
ECG Exercise Stress Test in Coronary Artery Disease
Author(s): Gaetano Antonio Lanza Added: 9 months ago

Guidelines & Statements